These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5455567)

  • 1. Effect of glycine loading on plasma and urinary uric acid and amino acids in normal and gouty subjects.
    Yü TF; Kaung C; Gutman AB
    Am J Med; 1970 Sep; 49(3):352-9. PubMed ID: 5455567
    [No Abstract]   [Full Text] [Related]  

  • 2. The kinetics of intramolecular distribution of 15N in uric acid after administration of (15N) glycine. A reappraisal of the significance of preferential labeling of N-(3+9) of uric acid in primary gout.
    Sperling O; Wyngaarden JB; Starmer CF
    J Clin Invest; 1973 Oct; 52(10):2468-85. PubMed ID: 4353999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uric acid metabolism in normal man and in primary gout.
    GUTMAN AB; YÜ TF
    N Engl J Med; 1965 Aug; 273(6):313-21. PubMed ID: 21417068
    [No Abstract]   [Full Text] [Related]  

  • 4. Uric acid production in normal and gouty subjects, determined by N15 labeled glycine.
    MULLER AF; BAUER W
    Proc Soc Exp Biol Med; 1953 Jan; 82(1):47-50. PubMed ID: 13037798
    [No Abstract]   [Full Text] [Related]  

  • 5. Incorporation of glycine-1-C14, glycine-2-C14 and glycine-N15 into uric acid in normal and gouty subjects.
    GUTMAN AB; YU TF; BLACK H; YALOW RS; BERSON SA
    Am J Med; 1958 Dec; 25(6):917-32. PubMed ID: 13606143
    [No Abstract]   [Full Text] [Related]  

  • 6. Uric acid metabolism in normal subjects and in gouty patients by chromatographic measurement of 14C-uric acid in plasma and urine.
    Bianchi R; Vitali C; Clerico A; Pilo A; Riente L; Fusani L; Mariani G
    Metabolism; 1979 Nov; 28(11):1105-13. PubMed ID: 491967
    [No Abstract]   [Full Text] [Related]  

  • 7. Uric acid nephrolithiasis in gout. Predisposing factors.
    Yü T; Gutman AB
    Ann Intern Med; 1967 Dec; 67(6):1133-48. PubMed ID: 6061930
    [No Abstract]   [Full Text] [Related]  

  • 8. Physiological characteristics of various experimental models for the study of disorders in purine metabolism.
    Musil J
    Adv Exp Med Biol; 1977; 76B():179-88. PubMed ID: 16457
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal excretion of urate in normal and gouty subjects at high, normal and low plasma urate levels.
    Fontenaille C; Guiheneuc P; Heron B; Prost A; Lucas J
    Biomedicine; 1974 Sep; 21(9):382-5. PubMed ID: 4457158
    [No Abstract]   [Full Text] [Related]  

  • 10. [Behavior of plasma and urine purines, after a purine-free diet, in normal subjects and patients with gout].
    Vannoni D; Porcelli B; Di Stefano A; Pizzichini M; Leoncini R; Terzuoli L; Taddeo A; Marsini S; Morozzi G; Marcolongo R
    Medicina (Firenze); 1989; 9(3):295-7. PubMed ID: 2615605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate of conversion of isotopic glycine to uric acid in the normal and gouty human and how this is affected by vitamin E and folic acid.
    BISHOP C; RAND R; TALBOTT JH
    Metabolism; 1955 Mar; 4(2):174-82. PubMed ID: 14355635
    [No Abstract]   [Full Text] [Related]  

  • 12. Uric acid production in a case of myeloid metaplasia associated with gouty arthritis, studied with N15 labeled glycine.
    LASTER L; MULLER AF
    Am J Med; 1953 Dec; 15(6):857-61. PubMed ID: 13104456
    [No Abstract]   [Full Text] [Related]  

  • 13. Calciuric effect of probenecid in gouty patients.
    Weinberger A; Schindel B; Liberman UA; Pinkhas J; Sperling O
    Isr J Med Sci; 1983 Apr; 19(4):377-9. PubMed ID: 6853140
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of benemid (p-[di-n-propylsulfamyl]-benzoic acid) on urate clearance and other discrete renal functions in gouty subjects.
    SIROTA JH; YU TF; GUTMAN AB
    J Clin Invest; 1952 Jul; 31(7):692-701. PubMed ID: 14938444
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of weight reduction on urate metabolism.
    Emmerson BT
    Adv Exp Med Biol; 1974; 41():429-33. PubMed ID: 4832567
    [No Abstract]   [Full Text] [Related]  

  • 16. Incorporation of glycine nitrogen into uric acid in normal and gouty man.
    BENEDICT JD; ROCHE M; YU TF; BIEN EJ; GUTMAN AB; STETTEN D
    Metabolism; 1952 Jan; 1(1):3-12. PubMed ID: 14890550
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term follow-up of incorporation of 15N from glycine into uric acid in gout.
    Yu TF; Roboz J
    Am J Med; 1981 Apr; 70(4):797-802. PubMed ID: 7211916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal glycine-C14-incorporation into uric acid in primary gout.
    WYNGAARDEN JB
    Metabolism; 1958 Jul; 7(4 Pt 1):374-5. PubMed ID: 13565391
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of weight loss on plasma and urinary uric acid and lipid levels.
    Scott JT; Sturge RA
    Adv Exp Med Biol; 1977; 76B():274-7. PubMed ID: 855753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The kidney and hyperuricaemia (author's transl)].
    Tcherdakoff P
    Munch Med Wochenschr; 1973 Sep; 115(38):1607-11. PubMed ID: 4800872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.